Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -57.86%.However, over the last six months, we can see a stronger performance of -47.68%. Over the last 30 days, the price of PSTV has fallen by 63.94%. And in the last five days, it has fallen by -21.02%.
Plus Therapeutics Inc (PSTV) currently has a stock price of $0.63. The stock saw a sharp increase in the last trading session, hitting a high of $20.5 after opening at $0.63. The lowest recorded price for the day was $3.0 before it closed at $0.54.
Plus Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $2.31 on 03/07/25, and the lowest price during that time was $0.16, recorded on 06/18/25.
52-week price history of PSTV Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Plus Therapeutics Inc’s current trading price is -72.82% away from its 52-week high, while its distance from the 52-week low is 284.27%. The stock’s price range for this period has been between $0.16 and $2.31. The Healthcare sector company’s shares saw a trading volume of about 12.88 million for the day, which was lower than the average daily volume of 31.66 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Plus Therapeutics Inc (PSTV) has experienced a quarterly rise of 23.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 62.33M and boasts a workforce of 21 employees.
Expert Opinions: Analysts’ Ratings for Plus Therapeutics Inc
As of right now, 1 analyst is rating Plus Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5525, with a change in price of -0.5121. Similarly, Plus Therapeutics Inc recorded 21,511,840 in trading volume during the last 100 days, posting a change of -44.92%.
PSTV’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PSTV stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
PSTV Stock Stochastic Average
As of today, the raw stochastic average of Plus Therapeutics Inc over the last 50 days is at 63.06%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 49.51%. Further, the company’s Stochastic %K and %D values for the last 20 days were 42.49% and 50.72%, respectively.
